X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (41) 41
hygiene (41) 41
medical or veterinary science (41) 41
preparations for medical, dental, or toilet purposes (41) 41
specific therapeutic activity of chemical compounds ormedicinal preparations (41) 41
humans (33) 33
female (23) 23
oncology (23) 23
adult (21) 21
male (20) 20
middle aged (20) 20
aged (18) 18
chemistry (18) 18
metallurgy (18) 18
organic chemistry (18) 18
peptides (17) 17
heterocyclic compounds (16) 16
drug administration schedule (10) 10
neoplasms - drug therapy (10) 10
antineoplastic agents - adverse effects (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
chemotherapy (8) 8
vinblastine - analogs & derivatives (8) 8
administration, oral (7) 7
antineoplastic agents - therapeutic use (7) 7
vinblastine - administration & dosage (7) 7
vinblastine - adverse effects (7) 7
aged, 80 and over (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
infusions, intravenous (6) 6
pharmacology & pharmacy (6) 6
treatment outcome (6) 6
vinorelbine (6) 6
5-fluorouracil (5) 5
antineoplastic agents - administration & dosage (5) 5
breast neoplasms - drug therapy (5) 5
cancer (5) 5
enzyme inhibitors - administration & dosage (5) 5
navelbine (5) 5
uracil - administration & dosage (5) 5
uracil - analogs & derivatives (5) 5
5-ethynyluracil 776c85 (4) 4
antineoplastic agents - pharmacokinetics (4) 4
carcinoma (4) 4
carcinoma - drug therapy (4) 4
care and treatment (4) 4
cells (4) 4
clinical trials as topic (4) 4
diphosphonates - adverse effects (4) 4
diphosphonates - therapeutic use (4) 4
enzyme inhibitors - adverse effects (4) 4
fluorouracil - administration & dosage (4) 4
imidazoles - therapeutic use (4) 4
modulation (4) 4
neoplasms - metabolism (4) 4
neutropenia - chemically induced (4) 4
phase i (4) 4
therapy (4) 4
vinblastine - therapeutic use (4) 4
advanced colorectal-cancer (3) 3
animals (3) 3
antimetabolites, antineoplastic - administration & dosage (3) 3
antineoplastic agents, phytogenic - administration & dosage (3) 3
antineoplastic agents, phytogenic - adverse effects (3) 3
area under curve (3) 3
aromatase inhibitors (3) 3
breast neoplasms - pathology (3) 3
colorectal neoplasms - drug therapy (3) 3
dihydrouracil dehydrogenase (3) 3
dosage and administration (3) 3
dose-response relationship, drug (3) 3
double-blind method (3) 3
enzyme inhibitors - pharmacokinetics (3) 3
epithelium - metabolism (3) 3
follow-up studies (3) 3
genetic therapy - methods (3) 3
half-life (3) 3
imidazoles - adverse effects (3) 3
index medicus (3) 3
lung neoplasms - pathology (3) 3
nasal mucosa - metabolism (3) 3
oxidoreductases - antagonists & inhibitors (3) 3
pharmacokinetics (3) 3
phase-ii (3) 3
research (3) 3
trial (3) 3
united states (3) 3
uracil - adverse effects (3) 3
zoledronic acid (3) 3
abridged index medicus (2) 2
accelerated radiotherapy (2) 2
adenovirus (2) 2
advanced breast-cancer (2) 2
agents (2) 2
anastrozole (2) 2
antimetabolites, antineoplastic - adverse effects (2) 2
antineoplastic agents - pharmacology (2) 2
biological availability (2) 2
biotechnology & applied microbiology (2) 2
bone density - drug effects (2) 2
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (82) 82
French (11) 11
German (6) 6
Chinese (3) 3
Norwegian (2) 2
Polish (2) 2
Portuguese (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2000, Volume 18, Issue 8, pp. 1758 - 1763
Journal Article
Journal of Oncology Practice, ISSN 1554-7477, 03/2010, Volume 6, Issue 2, pp. 107 - 110
Developing successful contracts is imperative for research sites conducting company-sponsored or investigator-initiated clinical trials. Good contracts help... 
165 | Practice of Research
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2000, Volume 18, Issue 4, pp. 915 - 926
Purpose: To determine the maximum-tolerated dose (MTD), toxicities, and pharmacokinetics of oral fluorouracil (5-FU) administered twice daily in combination... 
RAT-LIVER | CANCER-PATIENTS | ONCOLOGY | 5-FLUOROURACIL-BASED CHEMOTHERAPY | METASTATIC COLORECTAL-CARCINOMA | MONONUCLEAR-CELLS | TOXICITY | CONTINUOUS-INFUSION | FAMILIAL PYRIMIDINEMIA | 5-ETHYNYLURACIL 776C85 | MODULATION | Oxidoreductases - antagonists & inhibitors | Antimetabolites, Antineoplastic - pharmacokinetics | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Half-Life | Male | Metabolic Clearance Rate | Diarrhea - chemically induced | Antimetabolites, Antineoplastic - administration & dosage | Dose-Response Relationship, Drug | Enzyme Inhibitors - administration & dosage | Tissue Distribution | Fluorouracil - administration & dosage | Uracil - administration & dosage | Enzyme Inhibitors - pharmacokinetics | Fluorouracil - adverse effects | Aged, 80 and over | Adult | Female | Carcinoma - drug therapy | Enzyme Inhibitors - adverse effects | Drug Administration Schedule | Administration, Oral | Remission Induction | Uracil - adverse effects | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Fluorouracil - pharmacokinetics | Uracil - pharmacokinetics | Dihydrouracil Dehydrogenase (NADP) | Uracil - analogs & derivatives
Journal Article
Journal Article
Oncologist, ISSN 1083-7159, 11/2004, Volume 9, Issue 6, pp. 687 - 695
An open-label study conducted in community centers assessed the safety of zoledronic acid 4 mg intravenously over 15 minutes every 3-4 weeks as treatment of... 
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/1999, Volume 43, Issue 1, pp. 68 - 72
Purpose: Vinorelbine (Navelbine) is a semisynthetic vinca alkaloid with documented activity in breast cancer. The major dose-limiting toxicity (DLT) when given... 
Dose intensity | Breast cancer | Phase I | Vinorelbine | Growth factor
Journal Article
Journal Article
01/2007
The present invention relates to a method of treating a warm-blooded animal, especially a human, having mesothelioma, especially malignant mesothelioma,... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
03/2006
The present invention relates to a method of treating a warm-blooded animal, especially a human, having mesothelioma, especially malignant mesothelioma,... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.